DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $38.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price cut by Barrington Research from $41.00 to $38.00 in a report released on Friday, Benzinga reports. They currently have an outperform rating on the medical instruments supplier’s stock.

Other equities research analysts have also issued reports about the company. StockNews.com upgraded DENTSPLY SIRONA from a hold rating to a buy rating in a report on Friday, January 19th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a research note on Friday. Leerink Partnrs reissued an outperform rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. SVB Leerink assumed coverage on shares of DENTSPLY SIRONA in a report on Monday, February 26th. They set an outperform rating and a $42.00 price target on the stock. Finally, Needham & Company LLC reduced their price objective on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a research note on Friday. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and a consensus target price of $35.89.

DENTSPLY SIRONA Stock Down 0.3 %

XRAY stock opened at $28.29 on Friday. The company has a 50 day moving average of $32.13 and a two-hundred day moving average of $32.71. The company has a market cap of $5.87 billion, a price-to-earnings ratio of -64.29, a PEG ratio of 1.15 and a beta of 1.00. DENTSPLY SIRONA has a 12-month low of $26.27 and a 12-month high of $41.65. The company has a quick ratio of 0.95, a current ratio of 1.43 and a debt-to-equity ratio of 0.54.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.42. The business had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. DENTSPLY SIRONA’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.39 earnings per share. On average, equities analysts anticipate that DENTSPLY SIRONA will post 2.04 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were given a dividend of $0.16 per share. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.26%. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several large investors have recently made changes to their positions in XRAY. Bar Harbor Wealth Management acquired a new position in shares of DENTSPLY SIRONA during the fourth quarter worth approximately $4,931,000. DAVENPORT & Co LLC bought a new stake in DENTSPLY SIRONA in the 4th quarter valued at $1,220,000. Andra AP fonden grew its position in DENTSPLY SIRONA by 20.3% in the 3rd quarter. Andra AP fonden now owns 302,700 shares of the medical instruments supplier’s stock worth $10,340,000 after purchasing an additional 51,100 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of DENTSPLY SIRONA by 98.1% during the 3rd quarter. Envestnet Asset Management Inc. now owns 347,220 shares of the medical instruments supplier’s stock worth $11,861,000 after purchasing an additional 171,958 shares during the period. Finally, Mirabella Financial Services LLP acquired a new position in shares of DENTSPLY SIRONA during the third quarter valued at about $802,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.